Pinoys could be hesitant to get COVID vaccine because of Dengvaxia issue — Palace

 By Deighton Acuin and Archie Villaflores


Malacañang said Tuesday it cannot be denied that the use of Dengvaxia contributed to Filipinos’ COVID-19 vaccine hesitancy.

Presidential Spokesman Harry Roque said when he asked if the controversy affected the public’s decision of getting vaccinated against coronavirus.

“Hindi po natin mededeny na meron pong influence ‘yan,” Roque in an online briefing.

“‘Wag po natin pakinggan ‘yung mga self-proclaimed experts. Kasi ‘pag naapruban po ‘yan ng FDA [Food and Drug Administration] lalo na for general use at ginagamit sa buong mundo, wala pong dahilan para matakot tayo sa ganyang mga bakuna,” he added.

He also urged the public of being critical in searching information regarding vaccines and to express trust with the country’s Food and Drug Administration (FDA).

Nearly half of the Filipinos do not want to get inoculated against the infectious disease, according to a survey results released by Pulse Asia.

Last 2017, the Department of Health halted its anti-dengue vaccination drive after the Dengvaxia’s manufacturer Sanofi Pasteur said patients who received vaccine doses but does not have any exposure with the virus could experience severe symptoms.

By that time, around 80,000 children got vaccinated with the drug.

The Public Attorney’s Office filed complaints against health officials for the deaths of children allegedly caused by the anti-dengue vaccine, which is being widely used in other countries worldwide.

But in January 2019, DOH said no death was confirmed to have been directly caused by Dengvaxia.

RELATED ARTICLE: Philippine Daily Inquirer

Previous Post Next Post